Mirae Asset Global ETFs Holdings’s Tevogen Bio Holdings TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69K Sell
373
-9
-2% -$110 ﹤0.01% 3110
2025
Q4
$6.32K Buy
382
+119
+45% +$3.09K ﹤0.01% 3090
2025
Q3
$10.3K Sell
263
-7
-3% -$344 ﹤0.01% 3076
2025
Q2
$16.9K Sell
270
-13
-5% -$741 ﹤0.01% 2968
2025
Q1
$15.3K Buy
283
+12
+4% +$789 ﹤0.01% 3002
2024
Q4
$14K Buy
271
+10
+4% +$652 ﹤0.01% 3019
2024
Q3
$4.8K Buy
+261
New +$7.63K ﹤0.01% 3051

Other funds holding TVGN

Mirae Asset Global ETFs Holdings's TVGN Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Tevogen Bio Holdings (TVGN) stake by 2.4% in Q1 2026, selling an estimated $110 and leaving 373 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3110.

Mirae Asset Global ETFs Holdings first reported a position in TVGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $16.9K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 373 shares of Tevogen Bio Holdings worth $1.69K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings sold 9 Tevogen Bio Holdings shares in Q1 2026, an estimated $110.
  • Tevogen Bio Holdings made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #3110 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Tevogen Bio Holdings in Q3 2024 and has held it in 7 quarters since.
  • Mirae Asset Global ETFs Holdings's Tevogen Bio Holdings position peaked at $16.9K in Q2 2025.
  • 30 funds tracked by Wall St. Rank held Tevogen Bio Holdings as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.